Cases of euglycemic ketoacidosis during SGLT-2i therapy have been reported in patients with T2D and type 1 diabetes (off-label use) [Citation82,Citation83], most of which were associated with precipitating factors, such as infection, dose reduction or discontinuation of exogenous insulin therapy, alcohol use, and food restriction [Citation83]
Some individuals notice increased energy within a short period, while fat metabolism benefits may take a few weeks, depending on consistency and lifestyle
Always recalculate your dosing when changing vial sizes, even if you use the same water volume
IGF LR3 Product Information Compound Name Insulin Like Growth Factor Long R3 (IGF LR3) Net Content 1 mg Purity Greater than 99 percent (HPLC verified) Form Lyophilized powder Storage Store unreconstituted material at ?20C for long term stability
For labs and researchers relying on the impeccable purity of peptides, getting storage right isn't just best practice